HL Form 144: Trustee plans sale of 597,093 Hecla common shares on NYSE
Rhea-AI Filing Summary
Hecla Mining Company (HL) filed a Form 144 proposing the sale of 597,093 shares of common stock, with an aggregate market value of $4,561,791, through U.S. Bank Trust Services on the NYSE, approximately on 08/14/2025. The filing reports 669,983,628 shares outstanding. The securities to be sold were acquired by contributions to the Lucky Friday Pension Plan from Hecla Mining Company on 08/17/2020 (202,593 shares), 09/22/2021 (100,000 shares), 05/19/2022 (290,000 shares) and 10/16/2023 (4,500 shares). The filer states no securities sold in the past three months and certifies no undisclosed material adverse information.
Positive
- Full disclosure of proposed sale size: 597,093 shares with aggregate market value of $4,561,791 are reported
- Source of shares is documented: All shares originate from contributions to the Lucky Friday Pension Plan with specific dates and amounts provided
Negative
- None.
Insights
TL;DR: Routine Form 144 discloses a trustee-led proposed sale of 597,093 Hecla shares; the filing shows acquisitions were plan contributions and no recent sales.
The notice reports an intended disposition of 597,093 common shares valued at $4,561,791, to be transacted via U.S. Bank Trust Services on the NYSE around 08/14/2025. All shares scheduled for sale were acquired through contributions to the Lucky Friday Pension Plan on documented dates and amounts. The filing also indicates no securities sold in the past three months, which suggests this is a disclosed, scheduled trustee sale rather than an active trading pattern by the filer.
TL;DR: The Form 144 documents a transparent, planned sale of plan-contributed shares handled by a named trustee; disclosure requirements appear satisfied.
The submission names the broker (U.S. Bank Trust Services) and specifies that the shares were provided to the Lucky Friday Pension Plan by Hecla Mining Company on four dates with exact share counts. The filer affirms the absence of undisclosed material adverse information and reports no recent sales, meeting the procedural disclosures expected under Rule 144 for proposed restricted or control-person sales.